116 related articles for article (PubMed ID: 4209648)
21. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
Kasagi K; Hatabu H; Tokuda Y; Iida Y; Endo K; Konishi J
Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
Hyman BN; Johnson PC
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
[No Abstract] [Full Text] [Related]
23. [Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy].
Otter R; Wiersinga WM; Peeters HF; Bleeker GM; Touber JL
Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2189-93. PubMed ID: 6817147
[No Abstract] [Full Text] [Related]
24. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
Shenkman L; Mitsuma T; Hollander CS
J Clin Invest; 1973 Jan; 52(1):205-9. PubMed ID: 4629908
[TBL] [Abstract][Full Text] [Related]
25. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
26. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
Ridgway EC; Weintraub BD; Cevallos JL; Rack MC; Maloof F
J Clin Invest; 1973 Nov; 52(11):2783-92. PubMed ID: 4201265
[TBL] [Abstract][Full Text] [Related]
27. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
[TBL] [Abstract][Full Text] [Related]
29. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
[TBL] [Abstract][Full Text] [Related]
30. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
[No Abstract] [Full Text] [Related]
31. Clinical application of a cytochemical bioassay for the determination of thyroid stimulating hormone.
Hashimoto T; Döhler KD; Emrich D; von zur Mühlen A
J Endocrinol Invest; 1979; 2(4):395-400. PubMed ID: 119800
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
33. [Endocrine opthalmopathy-- new physiopathological viewpoints through the determination of T3, T4 and TSH following TRH stimulation].
Loos U; Rothenbuchner G; Birk J; Ishihara A; Pfeiffer EF
Verh Dtsch Ges Inn Med; 1974; 80():1340-3. PubMed ID: 4217981
[No Abstract] [Full Text] [Related]
34. [Behavior of the TSH level in thyroidectomized patients after thyrotropin releasing hormone (TRH)].
Piaszek L; Strötges MW
Nucl Med (Stuttg); 1976 Feb; 15(1):43-5. PubMed ID: 815889
[TBL] [Abstract][Full Text] [Related]
35. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
[No Abstract] [Full Text] [Related]
36. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the TSH and T3 response to exogenous TRH in patients made euthyroid after treatment with I 131 for hyperthyroidism].
Caputo M; Venerucci D; Trucchi M; Menozzi C; Biassoni P; Santaniello B; Bagnasco M; Ferrini O
Arch Maragliano Patol Clin; 1978; 34(1):15-26. PubMed ID: 122175
[No Abstract] [Full Text] [Related]
38. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Clifton-Bligh P; Burke G
J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
[TBL] [Abstract][Full Text] [Related]
39. A study of thyroid function after subtotal thyroidectomy for Graves' disease: particularly on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients.
Fukino O; Tamai H; Fujii S; Ohsako N; Matsubayashi S; Kuma K; Nagataki S
Acta Endocrinol (Copenh); 1983 May; 103(1):28-33. PubMed ID: 6407253
[TBL] [Abstract][Full Text] [Related]
40. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
